Author

A. Burgener

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

K. Birse· 2 shared A. Borgognone· 1 shared A. C. Collier· 1 shared A. R. Berard· 1 shared B. Clotet· 1 shared B. Mothe· 1 shared B. Oriol· 1 shared B. Richardson· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. Birse

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia Control

A. Borgognone, M. Noguera-Julian, B. Oriol, L. Noël-Romas, M. Ruiz-Riol, Y. Guillen, M. Parera, M. Casadella, C. Duran, M. C. Puertas, F. Catala-Moll, M. De Leon, S. Knodel, K. Birse, C. Manzardo, , R. Paredes

The paper identifies gut microbiome signatures, specifically the Bacteroidales/Clostridiales ratio, associated with HIV-1 reservoir size and viremia control in a clinical trial.

bioRxiv · Oct 3, 2021Immunology

Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection

S. M. Hughes, C. N. Levy, F. Calienes, J. D. Stekler, U. Pandey, L. Vojtech, A. R. Berard, K. Birse, L. Noel-Romas, B. Richardson, J. B. Golden, M. Cartwright, A. C. Collier, C. E. Stevens, M. E. Curlin, , F. Hladik

This study shows that oral TDF/FTC antiretroviral drugs induce a type I/III interferon signature in the gut without HIV infection, potentially affecting immune responses.

bioRxiv · Aug 3, 2020Immunology